Total planned funding: $668,620,537
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $123,583,374 |
Mozambique | $95,957,147 |
Tanzania | $88,327,981 |
South Africa | $68,775,501 |
Nigeria | $42,386,208 |
Uganda | $38,287,215 |
Ethiopia | $35,671,678 |
Malawi | $32,493,508 |
Haiti | $18,025,012 |
Democratic Republic of the Congo | $17,061,432 |
Côte d'Ivoire | $15,868,266 |
Rwanda | $14,389,998 |
Zambia | $14,227,000 |
Eswatini | $12,621,120 |
Botswana | $12,043,188 |
Angola | $7,165,000 |
Vietnam | $6,249,034 |
Namibia | $4,255,794 |
Lesotho | $3,673,904 |
Zimbabwe | $3,600,000 |
South Sudan | $3,300,000 |
Caribbean Region | $2,380,000 |
India | $2,000,000 |
Central Asia Region | $1,979,658 |
Cameroon | $1,740,000 |
Ukraine | $1,050,000 |
Ghana | $670,000 |
Guyana | $388,519 |
Burundi | $300,000 |
Dominican Republic | $100,000 |
Asia Regional Program | $50,000 |
Russia | $0 |
Central America Region | $0 |
China | $0 |
Organizational Types
University | $668,620,537 |
Program Areas
Treatment | $244,386,282 |
Prevention | $150,987,324 |
Governance and Systems | $136,530,136 |
Care | $110,471,298 |
Testing | $25,963,883 |
Budget Codes
HTXS: Treatment: Adult Treatment | $205,644,980 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $70,924,327 |
HVSI: Strategic Information | $69,846,763 |
OHSS: Health Systems Strengthening | $48,083,168 |
HBHC: Care: Adult Care and Support | $47,910,220 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $37,445,618 |
PDTX: Treatment: Pediatric Treatment | $35,524,016 |
HVTB: Care: TB/HIV | $33,286,921 |
HVCT: Testing: HIV Testing and Counseling | $25,963,883 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,568,727 |
HLAB: Laboratory Infrastructure | $18,600,205 |
PDCS: Care: Pediatric Care and Support | $17,563,632 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,645,285 |
HKID: Care: Orphans and Vulnerable Children | $11,710,525 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,297,185 |
HTXD: Treatment: ARV Drugs | $3,217,286 |
HMIN: Biomedical Prevention: Injection Safety | $1,234,649 |
HMBL: Biomedical Prevention: Blood Safety | $871,533 |